Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Its Hematology products include ADVATE (Antihemophilic Factor (Recombinant)), ADYNOVATE/ADYNOVI (Antihemophilic Factor (Recombinant), PEGylated)), RIXUBIS (Coagulation Factor IX (Recombinant)), VONVENDI (von Willebrand factor (Recombinant)) and FEIBA (Anti-Inhibitor Coagulant Complex). Its Genetic Diseases products include CINRYZE (C1 esterase inhibitor (human)), FIRAZYR (icatibant), ELAPRASE (idursulfase), REPLAGAL (agalsidase alfa) and VPRIV (velaglucerase alfa).
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Pharmaceuticals - NEC
- Sub-Industry: N/A
- Symbol: LON:SHP
- CUSIP: N/A
- Web: www.shire.com
- Market Cap: £40.87 billion
- Outstanding Shares: 904,099,000
- 50 Day Moving Avg: GBX 4,566.72
- 200 Day Moving Avg: GBX 4,619
- 52 Week Range: GBX 2,707.19 - GBX 5,377
Sales & Book Value:
- Trailing P/E Ratio: 139.08
- P/E Growth: 0.91
- Annual Revenue: £13.26 billion
- Price / Sales: 3.08
- Book Value: GBX 32.89 per share
- Price / Book: 1.37
- EBIDTA: £5.31 billion
- Net Margins: 9.95%
- Return on Equity: 4.85%
- Return on Assets: 2.14%
- Average Volume: 2.38 million shs.
Frequently Asked Questions for Shire PLC (LON:SHP)
What is Shire PLC's stock symbol?
Shire PLC trades on the London Stock Exchange (LON) under the ticker symbol "SHP."
How often does Shire PLC pay dividends? What is the dividend yield for Shire PLC?
Shire PLC declared a dividend on Thursday, February 16th. Shareholders of record on Thursday, March 9th will be given a dividend of GBX 20.64 per share on Tuesday, April 25th. This represents a dividend yield of 0.43%. The ex-dividend date of this dividend is Thursday, March 9th. This is a boost from Shire PLC's previous dividend of $3.51. The official announcement can be viewed at this link. View Shire PLC's Dividend History.
When will Shire PLC make its next earnings announcement?
Where is Shire PLC's stock going? Where will Shire PLC's stock price be in 2017?
17 equities research analysts have issued twelve-month price objectives for Shire PLC's stock. Their predictions range from GBX 4,450 to GBX 6,970. On average, they expect Shire PLC's stock price to reach GBX 6,005.60 in the next twelve months. View Analyst Ratings for Shire PLC.
Who are some of Shire PLC's key competitors?
Some companies that are related to Shire PLC include AstraZeneca plc (AZN), Shire PLC (SHPG), Teva Pharmaceutical Industries Limited (TEVA), Dr. Reddy's Laboratories Ltd (RDY), Valeant Pharmaceuticals International (VRX), Patheon NV (PTHN), Taro Pharmaceutical Industries (TARO), Catalent (CTLT), Akorn (AKRX), Opko Health (OPK), Hikma Pharmaceuticals Plc (HIK), BTG plc (BTG), Theravance Biopharma (TBPH), Cambrex Corporation (CBM), Horizon Pharma PLC (HZNP), Pacira Pharmaceuticals (PCRX), Amicus Therapeutics (FOLD) and Innoviva (INVA).
Who are Shire PLC's key executives?
Shire PLC's management team includes the folowing people:
- Flemming Ornskov M.D., Chief Executive Officer, Executive Director
- Jeffrey Poulton, Chief Financial Officer, Executive Director
- William Mordan, General Counsel, Company Secretary
- Perry Sternberg, Head - U.S. Commercial
- Kim Stratton, Head - International Commercial
- Philip J. Vickers, Head - Research and Development
- Matthew Walker, Head - Technical Operations
- Susan Saltzbart Kilsby, Independent Non-Executive Chairman of the Board
- Olivier Bohuon, Non-Executive Director
- Ian T. Clark, Non-Executive Director
How do I buy Shire PLC stock?
Shares of Shire PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Shire PLC's stock price today?
MarketBeat Community Rating for Shire PLC (LON SHP)MarketBeat's community ratings are surveys of what our community members think about Shire PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Shire PLC stock can currently be purchased for approximately GBX 4,520.
Consensus Ratings for Shire PLC (LON:SHP) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 1 Hold Rating, 14 Buy Ratings, 1 Strong Buy Rating|
|Consensus Rating:||Buy (Score: 2.88)|
|Consensus Price Target: ||GBX 6,005.60|
Analysts' Ratings History for Shire PLC (LON:SHP)
(Data available from 6/28/2015 forward)
|6/28/2017||Liberum Capital||Reiterated Rating||Hold||GBX 4,900|
|6/28/2017||Goldman Sachs Group, Inc. (The)||Lower Price Target||Conviction-Buy||GBX 6,800 -> GBX 6,400|
|6/27/2017||Royal Bank Of Canada||Reiterated Rating||Outperform|
|6/27/2017||Credit Suisse Group||Reiterated Rating||Outperform||GBX 5,350|
|6/27/2017||Barclays PLC||Reiterated Rating||Overweight||GBX 6,300|
|6/27/2017||Deutsche Bank AG||Reiterated Rating||Buy||GBX 6,000|
|6/27/2017||J P Morgan Chase & Co||Reiterated Rating||Overweight|
|6/22/2017||Citigroup Inc.||Reiterated Rating||Buy||GBX 6,500|
|6/21/2017||Shore Capital||Reiterated Rating||Buy|
|6/9/2017||Jefferies Group LLC||Lower Price Target||Buy||GBX 6,400 -> GBX 5,600|
|6/8/2017||Berenberg Bank||Lower Price Target||Buy||GBX 6,100 -> GBX 6,000|
|5/19/2017||HSBC Holdings plc||Downgrade||Reduce||GBX 4,550 -> GBX 4,450|
|4/3/2017||BNP Paribas||Reiterated Rating||Outperform||GBX 5,900|
|3/23/2017||Societe Generale||Reiterated Rating||Buy||GBX 6,200|
|1/9/2017||Bryan, Garnier & Co||Reiterated Rating||Buy||GBX 6,800|
|11/7/2016||AlphaValue||Reiterated Rating||Buy||GBX 6,714|
|11/3/2016||Bank of America Corporation||Reiterated Rating||Buy||GBX 6,970|
|6/3/2016||Morgan Stanley||Reiterated Rating||Overweight||GBX 5,600|
|3/15/2016||Sanford C. Bernstein||Reiterated Rating||Outperform||GBX 5,000|
|1/12/2016||S&P Equity Research||Reiterated Rating||Buy|
|11/3/2015||Kepler Capital Markets||Lower Price Target||Buy||GBX 6,000 -> GBX 5,900|
Earnings History for Shire PLC (LON:SHP)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Shire PLC (LON:SHP)
Current Year EPS Consensus Estimate: $5.01 EPS
Dividend History by Quarter for Shire PLC (LON SHP)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Shire PLC (LON:SHP)Insider Trades by Quarter for Shire PLC (LON:SHP)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/31/2017||William Burns||Insider||Buy||136||GBX 4,742||£6,449.12|
|12/16/2016||Olivier Bohuon||Insider||Buy||141||GBX 4,528||£6,384.48|
|9/30/2016||Dominic Blakemore||Insider||Buy||133||GBX 5,010||£6,663.30|
|9/30/2015||Blakemore ,Dominic||Insider||Buy||129||GBX 4,498||£5,802.42|
|6/30/2015||Kappler,David J||Insider||Buy||126||GBX 51.05||GBX 6,432.30|
|3/31/2015||Susan Kilsby||Insider||Buy||375||GBX 5,327||£19,976.25|
|12/19/2014||Steven Gillis||Insider||Buy||228||GBX 4,654||£10,611.12|
|10/30/2014||Steven Gillis||Insider||Buy||381||GBX 4,098||£15,613.38|
Headline Trends for Shire PLC (LON:SHP)
Latest Headlines for Shire PLC (LON:SHP)
Shire PLC (SHP) Chart for Wednesday, June, 28, 2017